# Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea

> **NCT02614781** · — · COMPLETED · sponsor: **Nordic Pharma SAS** · enrollment: 892 (actual)

## Conditions studied

- Medical Termination of Pregnancy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02614781
- **Lead sponsor:** Nordic Pharma SAS
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 892 (ACTUAL)
- **Last updated:** 2016-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02614781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02614781, "Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02614781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*